Literature DB >> 12218466

Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group.

Roy W Beck1.   

Abstract

The Pediatric Eye Disease Investigator Group (PEDIG) is a network of university-based and community-based pediatric eye care practitioners that is conducting multiple clinical research studies. The group has conducted the Congenital Esotropia Observational Study, which assessed the early course of esotropia in infants, and the Amblyopia Treatment Studies, a series of randomized trials, the first of which compared atropine and patching for treatment of moderate amblyopia in children 3 to <7 years old. Herein, the results of these studies are summarized, and the current and future studies of the group are described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218466     DOI: 10.1097/00055735-200210000-00008

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  4 in total

1.  Characterising the orientation-specific pattern-onset visual evoked potentials in children with bilateral refractive amblyopia and non-amblyopic controls.

Authors:  Tiong Peng Yap; Chi D Luu; Catherine M Suttle; Audrey Chia; Mei Ying Boon
Journal:  Doc Ophthalmol       Date:  2020-09-23       Impact factor: 2.379

2.  Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.

Authors:  Anne M Comi; Mustafa Sahin; Adrienne Hammill; Emma H Kaplan; Csaba Juhász; Paula North; Karen L Ball; Alex V Levin; Bernard Cohen; Jill Morris; Warren Lo; E Steve Roach
Journal:  Pediatr Neurol       Date:  2016-03-16       Impact factor: 3.372

3.  How does anisometropia affect the choroidal vascularity index?

Authors:  Selim Cevher; Mehmet Barış Üçer; Tayfun Şahin
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

4.  Optical coherence tomographic angiography in children with anisometropic amblyopia.

Authors:  Chenchen Liu; Yanzhen Zhang; Xiaopeng Gu; Puying Wei; Dehai Zhu
Journal:  BMC Ophthalmol       Date:  2022-06-20       Impact factor: 2.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.